Notably, SYNC was downregulated in AD (Figure 9C), while MAPK1IP1L was upregulated in AD (Figure 9D), suggesting their attractiveness as prognostic biomarkers for AD with high m6A background. Here, SYNC is linked to Alzheimer disease.